Fig. 6
From: Are malaria elimination efforts on right track? An analysis of gains achieved and challenges ahead
Prevalence of antimalarial resistance markers: Percent prevalence of potential antimalarial resistance markers in P. falciparum in different endemic countries; (a) pfcrt 76 K/T mutation for chloroquine (data from 1955 to 2018) and (b) kelch 13 mutation for ACT drugs in different WHO regions. (Figure reproduced from WWARN Molecular Surveyor: assessed on 02 Jun 2018)